Education
About Us
Working with TipRanks
Follow Us
Nulab Inc. (JP:5033)
:5033
Top Page
Nulab Inc.
(5033)
Rating:71Outperform
Price Target:
¥1,045.00
▲(15.60%Upside)
Nulab Inc. (5033) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.98B
Dividend YieldN/A
Average Volume (3M)97.82K
Price to Earnings (P/E)10.6
Beta (1Y)1.26
Revenue Growth12.27%
EPS Growth78.43%
CountryJP
Employees159
SectorTechnology
Sector Strength83
IndustrySoftware - Application
Share Statistics
EPS (TTM)23.69
Shares Outstanding6,484,101
10 Day Avg. Volume91,090
30 Day Avg. Volume97,816
Financial Highlights & Ratios
PEG Ratio-2.00
Price to Book (P/B)3.64
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nulab Inc. Business Overview & Revenue Model
Company DescriptionNulab Inc. (5033) is a technology company specializing in collaborative software solutions. The company operates in the information technology sector, providing a suite of products designed to enhance team collaboration and productivity. Its core offerings include tools for project management, diagramming, and team chat, serving a diverse range of industries from small businesses to large enterprises.
How the Company Makes MoneyNulab Inc. generates revenue primarily through a subscription-based model, where customers pay for access to its software tools on a monthly or annual basis. Key revenue streams include subscriptions for its flagship products such as Backlog, a project management tool; Cacoo, a cloud-based diagramming application; and Typetalk, a team chat platform. The company has also established significant partnerships with other technology and service providers to expand its market reach and enhance the functionality of its products. Additionally, Nulab may engage in strategic collaborations that contribute to its revenue growth by increasing its customer base and enhancing its product offerings.
Nulab Inc. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 4.04B | 3.66B | 2.71B | 2.33B | 1.94B | 1.58B | Gross Profit |
| 2.87B | 2.64B | 1.73B | 1.42B | 1.09B | 784.00M | EBIT |
| 456.87M | 332.12M | 101.15M | 167.35M | -6.77M | -40.00M | EBITDA |
| 532.46M | 424.12M | 179.14M | 266.01M | 66.69M | 29.10M | Net Income Common Stockholders |
| 340.84M | 308.16M | 88.42M | 197.88M | -25.53M | -52.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 3.25B | 2.48B | 1.74B | 1.13B | 878.98M | 843.00M | Total Assets |
| 3.93B | 3.47B | 2.61B | 1.62B | 1.33B | 1.28B | Total Debt |
| 3.00M | 5.25M | 13.75M | 58.69M | 154.21M | 272.00M | Net Debt |
| -3.25B | -2.48B | -1.73B | -1.07B | -724.76M | -571.00M | Total Liabilities |
| 2.19B | 2.14B | 1.65B | 1.23B | 1.15B | 2.92M | Stockholders Equity |
| 1.74B | 1.33B | 958.63M | 391.25M | 182.66M | 218.00M |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 694.57M | 169.40M | 321.29M | 153.73M | 0.00 | Operating Cash Flow |
| 0.00 | 811.90M | 297.32M | 401.01M | 242.03M | 0.00 | Investing Cash Flow |
| 0.00 | -110.72M | -130.74M | -74.35M | -80.91M | 0.00 | Financing Cash Flow |
| 0.00 | 16.87M | 417.41M | -95.27M | -119.66M | 0.00 |
Nulab Inc. Technical Analysis
Negative
904.00
Price Trends
994.22
Negative
938.64
Negative
867.97
Positive
Market Momentum
-26.82
Positive
42.43
Neutral
19.93
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5033, the sentiment is Negative. The current price of 904 is below the 20-day moving average (MA) of 941.85, below the 50-day MA of 994.22, and above the 200-day MA of 867.97, indicating a neutral trend. The MACD of -26.82 indicates Positive momentum. The RSI at 42.43 is Neutral, neither overbought nor oversold. The STOCH value of 19.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5033.
Nulab Inc. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥6.11B | 13.18 | 3.45% | 15.30% | 14.43% | ||
78 Outperform | ¥6.06B | 21.96 | ― | 29.19% | ― | ||
78 Outperform | ¥4.99B | 11.58 | 1.17% | 59.60% | 353.05% | ||
74 Outperform | ¥6.06B | 32.43 | ― | 17.25% | ― | ||
71 Outperform | ¥5.98B | 10.60 | ― | 12.27% | 78.43% | ||
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% | |
61 Neutral | ¥5.67B | 41.92 | 1.65% | 2.76% | -47.70% |
* Technology Sector Average
Performance Comparison
JP:5033
Nulab Inc.
904.00
-36.00
-3.83%
JP:3653
Morpho, Inc.
1,139.00
-482.00
-29.73%
JP:4372
YMIRLINK,Inc.
1,600.00
315.31
24.54%
JP:4379
Photosynth inc.
378.00
16.00
4.42%
JP:4428
Sinops, Inc.
900.00
-189.84
-17.42%
JP:4440
WITZ Corp.
1,234.00
458.65
59.15%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.